Selected aspects of genetic counselling for BRCA1 mutation carriers

被引:0
|
作者
Jacek Gronwald
机构
[1] Department of Genetics and Pathology,International Hereditary Cancer Center
来源
Hereditary Cancer in Clinical Practice | / 5卷
关键词
breast cancer; ovarian cancer; risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
This work consists of six parts based on seven manuscripts dealing with some aspects of genetic counselling for BRCA1 mutation carriers. It was demonstrated that the risk of breast and ovarian cancer in first-degree relatives of BRCA1 mutation carriers depends on the type of mutation and is higher in the younger generation. It was also shown that risk of breast cancer, but not of ovarian cancer, is related to cancer type of the proband. These factors should be taken into account when assessing risk of breast and ovarian cancer in relatives of BRCA1 mutation carriers. It was observed that longer breast-feeding, physical activities delaying menarche, preventive oophorectomy, administration of tamoxifen to patients with intact genital tract, and use of contraceptives reduce the risk of breast and ovarian cancer. All these possibilities should be presented to BRCA1 mutation carriers within the framework of cancer risk reduction options. It was also observed that there may be some preference in transmission of the mutant allele to female offspring of BRCA1 founder mutation carriers. Environmental factors appear also to interfere with transmission. The male to female ratio in offspring of BRCA1 mutation carriers is the same as for the general population. As for the consequences of simplified two-stage genetic counselling, the first psychological reaction of a female to the fact that she is a carrier of the BRCA1 mutation is negative. However, understanding that the risk of cancer is high persuades the woman to embrace preventive options. 98% of BRCA1 mutation carriers disclosed during population screening initiated and promoted by the media are convinced of the value of genetic testing. Simplified two-stage genetic counselling appears to be a useful approach promoting increased turnout for BRCA1 mutation testing.
引用
收藏
相关论文
共 50 条
  • [21] Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Antoniou, Antonis C.
    ENDOCRINE-RELATED CANCER, 2016, 23 (10) : T69 - T84
  • [22] Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Jane C. Figueiredo
    Robert W. Haile
    Jonine L. Bernstein
    Current Breast Cancer Reports, 2009, 1 (3) : 139 - 147
  • [23] Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers
    Johannsson, O
    Loman, N
    Möller, T
    Kristoffersson, U
    Borg, Å
    Olsson, H
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (08) : 1248 - 1257
  • [24] Surgical treatment in ovarian cancer prevention in carriers of the BRCA1/BRCA2 mutation
    Synowiec, Agnieszka
    Wcislo, Gabriel
    Bodnar, Lubomir
    Szczylik, Cezary
    GINEKOLOGIA POLSKA, 2012, 83 (01) : 51 - 56
  • [25] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [26] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [27] The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers
    Ko, Kwang-Pil
    Kim, Shana J.
    Huzarski, Tomasz
    Gronwald, Jacek
    Lubinski, Jan
    Lynch, Henry T.
    Armel, Susan
    Park, Sue K.
    Karlan, Beth
    Singer, Christian F.
    Neuhausen, Susan L.
    Narod, Steven A.
    Kotsopoulos, Joanne
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (11) : 2263 - 2272
  • [28] Genetic anticipation of breast cancer among BRCA1/BRCA2 mutation carriers: A retrospective study
    Kedmi, Aviya
    Kadouri, Luna
    Sagy, Iftach
    Hamburger, Tamar
    Levin, Gabriel
    Zimhony-Nissim, Noa
    Peretz, Tamar
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 159 (02) : 537 - 543
  • [29] The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers
    Mazzola, Emanuele
    Cheng, Su-Chun
    Parmigiani, Giovanni
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 315 - 318
  • [30] Defining Variations in Survival of BRCA1 and BRCA2 Mutation Carriers
    Grann, Victor R.
    Parsons, Ramon E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (14): : 1597 - 1598